Temenos AG
SIX:TEMN
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
52.7599
89
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Temenos AG
Cash Equivalents
Temenos AG
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Temenos AG
SIX:TEMN
|
Cash Equivalents
$107.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-2%
|
||
Crealogix Holding AG
SIX:CLXN
|
Cash Equivalents
CHf6.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Temenos AG
Glance View
In the heart of the bustling financial software landscape, Temenos AG stands as a stalwart, deftly steering its course through the evolving currents of banking technology. Founded in Geneva in 1993, Temenos has scripted its success story by crafting cutting-edge software solutions that empower banks and other financial institutions worldwide. Their flagship product, the Temenos T24 core banking system, acts as the backbone for more than 3,000 banking clients, encompassing retail, corporate, private wealth, and Islamic banking sectors. This software helps banks transform their operations, enhancing customer experiences, reducing costs, and ensuring compliance with increasingly stringent regulations. Temenos has built a robust business model centered around licensing and subscription services. While traditional software licensing provided a significant chunk of their revenue in earlier years, the pivot toward a subscription-based model aligns with industry trends favoring software-as-a-service (SaaS). This strategic shift ensures steady, recurring revenue streams, bolstering their financial stability. Additionally, the company extends its reach through a broad ecosystem of fintech partners and an expanding portfolio of modular products. Through these avenues, Temenos enables banks to integrate and customize solutions that cater to their unique needs, ultimately cementing its reputation as a versatile and indispensable player in the global banking software industry.
See Also
What is Temenos AG's Cash Equivalents?
Cash Equivalents
107.3m
USD
Based on the financial report for Sep 30, 2024, Temenos AG's Cash Equivalents amounts to 107.3m USD.
What is Temenos AG's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-2%
Over the last year, the Cash Equivalents growth was 23%. The average annual Cash Equivalents growth rates for Temenos AG have been 8% over the past three years , 7% over the past five years , and -2% over the past ten years .